Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-blind, Placebo-controlled Trial

Milnacipran, a serotonin/norepinephrine reuptake inhibitor (SNRI), is FDA-approved for the treatment of fibromyalgia (FM). This report presents the results of a randomized, double-blind, placebo-controlled trial of milnacipran conducted to test the hypotheses that (a) similar to patients with chroni...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Pain
Huvudupphovsmän: Natelson, Benjamin H., Vu, Diana, Mao, Xiangling, Weiduschat, Nora, Togo, Fumiharu, Lange, Gudrun, Blate, Michelle, Kang, Guoxin, Coplan, Jeremy D., Shungu, Dikoma C.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4630071/
https://ncbi.nlm.nih.gov/pubmed/26335989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpain.2015.08.004
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk